Management of a patient diagnosed with ovarian cancer during pregnancy
- Authors: Protasova A.E.1,2,3,4, Zazerskaya I.E.1, Tsypurdeyeva A.A.2,4,5, Shelepova E.S.1, Vyshedkevich E.D.1, Rizhinashvili I.A.1, Sokolova A.А.1
-
Affiliations:
- V.A. Almazov National Medical Research Centre
- Saint Petersburg State University
- North-Western State Medical University named after I.I. Mechnikov
- AVA-PETER Ltd.
- The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott
- Issue: Vol 70, No 3 (2021)
- Pages: 135-141
- Section: Theory and Practice
- URL: https://ogarev-online.ru/jowd/article/view/65225
- DOI: https://doi.org/10.17816/JOWD65225
- ID: 65225
Cite item
Abstract
Insufficient diagnosis of ovarian tumors during pregnancy and decreased oncological alertness constitute huge problems that can subsequently have an unfavorable outcome for both the pregnant woman and the fetus. The difficulties of diagnosing and treating ovarian cancer during pregnancy were demonstrated on the following clinical case example. In pregnant patient A. at 19-20 weeks of pregnancy, a lesion was found in the area of the right appendages (100.9 × 55.4 × 93.4 mm, V = 273 cm3), with many tissue partitions and parietal tissue inclusions. The growth of the neoplasm was noted (CA-125 884 U / ml) and the pain syndrome occurred in the patient at 23-24 weeks of pregnancy. Magnetic resonance imaging revealed a solid-cystic neoplasm of the right ovary (cystadenoma?) and surgery was performed in November 2019. Based on the results of histological examination, a high-grade serous ovarian cancer was diagnosed without signs of microsatellite instability MSI-H/dMMR (in the right ovary, in the biopsy of the left fallopian tube). The patient. received two cycles of polychemotherapy (TC scheme). The treatment was tolerated satisfactorily (CA-125 287.3 U / ml). At a gestational age of 34 6/7 weeks (January 2020), a simultaneous operation was performed, including a lower midline laparotomy, a lower uterine segment caesarean section, extirpation of the uterus with appendages, and an omentectomy. A boy was born (weight 2280 g, height 44 cm) with the Apgar score of 7/7 points, with no complications noticed in the postpartum period. Postoperative histological examination showed metastasis of carcinoma in the left ovary with signs of therapeutic pathomorphosis. The treatment was completed in March 2020 after six cycles of polychemotherapy.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Anna E. Protasova
V.A. Almazov National Medical Research Centre; Saint Petersburg State University; North-Western State Medical University named after I.I. Mechnikov; AVA-PETER Ltd.
Author for correspondence.
Email: protasova1966@yandex.ru
SPIN-code: 4097-0969
MD, Dr. Sci. (Med.), Professor
Russian Federation, Saint PetersburgIrina E. Zazerskaya
V.A. Almazov National Medical Research Centre
Email: zazera@mail.ru
SPIN-code: 5683-6741
MD, Dr. Sci. (Med.)
Russian Federation, Saint PetersburgAnna A. Tsypurdeyeva
Saint Petersburg State University; AVA-PETER Ltd.; The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott
Email: tsypurdeeva@mail.ru
SPIN-code: 5208-9707
MD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgEkaterina S. Shelepova
V.A. Almazov National Medical Research Centre
Email: shelepowa@gmail.com
SPIN-code: 9474-1351
MD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgElena D. Vyshedkevich
V.A. Almazov National Medical Research Centre
Email: lenavish04@gmail.com
SPIN-code: 5856-6500
Russian Federation, Saint Petersburg
Inna A. Rizhinashvili
V.A. Almazov National Medical Research Centre
Email: innaenuk@gmail.com
Russian Federation, Saint Petersburg
Alyona А. Sokolova
V.A. Almazov National Medical Research Centre
Email: alyona-sokolova@mail.ru
SPIN-code: 2423-0370
Russian Federation, Saint Petersburg
References
- Leiserowitz GS, Xing G, Cress R, et al. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol. 2006;101(2):315–321. doi: 10.1016/j.ygyno.2005.10.022
- Schmeler KM, Mayo-Smith WW, Peipert JF, et al. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol. 2005;105(5 Pt 1):1098–1103. doi: 10.1097/01.AOG.0000157465.99639.e5
- Smith LH, Dalrymple JL, Leiserowitz GS, et al. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184(7):1504–1513. doi: 10.1067/mob.2001.114867
- FIGO news. International Federation of Gynecology and Obstetrics. Treating cancer during pregnancy. [cited 2021 Apr 25]. Available from: https://www.figo.org/news/treating-cancer-during-pregnancy-0016145
- Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705–2712. doi: 10.1001/jama.291.22.2705
- Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221–227. doi: 10.1002/cncr.22371
- Palmer J, Vatish M, Tidy J. Epithelial ovarian cancer in pregnancy: a review of the literature. BJOG. 2009;116(4):480–491. doi: 10.1111/j.1471-0528.2008.02089.x
- Domini D, Campagna G, Coianiz A, et al. Mucinous adenocarcinoma of the ovary in pregnancy. Minerva Ginecol. 1999;51(3):99–101.
- Burke TW, Gershenson DM, Morris M, et al. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994;55(1):47–50. doi: 10.1006/gyno.1994.1245
- ESMO European Society for Medical Oncology. ECC 2015 Press prelease: a cancer diagnosis while pregnant should not lead to treatment delay or pregnancy termination. [cited 2021 Apr 25]. Available from: https://www.esmo.org/Conferences/Past-Conferences/European-Cancer-Congress-2015/News/A-Cancer-Diagnosis-While-Pregnant-Should-Not-Lead-to-Treatment-Delay-or-Pregnancy-Termination
Supplementary files
